CRANBURY, N.J., Feb. 10, 2025 /PRNewswire/ — Palatin Technologies, Inc. (NYSE American: PTN) will announce its second quarter fiscal year 2025 operating results on Thursday, February 13, 2025, before the open of the U.S. financial markets.
Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on February 13, 2025, at 11:00 a.m. ET. The conference call will include a review of the company’s operating results and an update on programs under development.
|
Schedule for the Operating Results Press Release, Conference Call / Audio Webcast |
|
|
Q2 Fiscal Year 2025 Results Press Release |
02/13/2025 at 7:30 a.m. ET |
|
Q2 Fiscal Year 2025 Conference Call-Live |
02/13/2025 at 11:00 a.m. ET |
|
US Toll Free Dial-In Number: |
1-888-506-0062 |
|
International Dial-In Number: |
1-973-528-0011 |
|
Participant Access Code: |
882092 |
|
Q2 Fiscal Year 2025 Conference Call-Replay |
02/13/2025-02/27/2025 |
|
US Toll Free Dial-In Number: |
1-877-481-4010 |
|
International Dial-In Number: |
1-919-882-2331 |
|
Participant Access Code: |
52016 |
The audio webcast and replay can be accessed by logging on to the “Investors-Webcasts” section of Palatin’s website at http://www.palatin.com or by clicking here.
About Palatin
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin’s strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin’s website at www.palatin.com and follow Palatin on Twitter at @PalatinTech.
SOURCE Palatin Technologies, Inc.
NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…
AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…
Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…
Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…
Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…
Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…